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Acetyl hexapeptide-3 has been used in anti-aging topical formulations aimed at improving skin 
appearance. However, few basic studies address its effects on epidermis and dermis, when vehiculated 
in topical formulations. Thus, the objective of this study was to determine the clinical efficacy of acetyl 
hexapeptide-3 using biophysical techniques. For this purpose, formulations with and without acetyl 
hexapeptide-3 were applied to the ventral forearm and the face area of forty female volunteers. Skin 
conditions were evaluated after 2 and 4-week long daily applications, by analyzing the stratum corneum 
water content and the skin mechanical properties, using three instruments, the Corneometer® CM 825, 
CutometerSEM 575 and ReviscometerRV600. All formulations tested increased the stratum corneum 
water content in the face region, which remained constant until the end of the study. In contrast, only 
formulations containing acetyl hexapeptide-3 exhibit a significant effect on mechanical properties, 
by decreasing the anisotropy of the face skin. No significant effects were observed in viscoelasticity 
parameters. In conclusion, the effects of acetyl hexapeptide-3 on the anisotropy of face skin characterize 
the compound as an effective ingredient for improving conditions of the cutaneous tissue, when used in 
anti-aging cosmetic formulations. 
Uniterms: Acetyl hexapeptide-3/use in cosmetic formulations. Acetyl hexapeptide-3/clinical efficacy. 
Biophysical techniques. Anti-aging/cosmetics. Clinical efficacy. Cosmetics.
Acetil hexapeptídeo-3 tem sido utilizado como um ingrediente ativo em formulações tópicas 
antienvelhecimento para a melhoria da aparência cutânea. No entanto, poucos estudos avaliam seus efeitos 
na epiderme e derme, quando veiculado em formulações tópicas. Portanto, o objetivo desse estudo foi 
a determinação da eficácia clínica de acetil hexapeptídeo-3 utilizando técnicas de biofísica e de análise 
de imagem. Para tal, formulações contendo, ou não, acetil hexapeptídeo-3 foram aplicadas no antebraço 
volar e na face de voluntárias. As condições cutâneas foram avaliadas após duas e quatro semanas de 
aplicação diária das formulações, por meio da análise no conteúdo aquoso do estrato córneo e avaliação 
das propriedades mecânicas da pele, utilizando os equipamentos Corneometer® CM 825, CutometerSEM 
575 e ReviscometerRV600. Todas as formulações avaliadas aumentaram o conteúdo aquoso do estrato 
córneo na face, o qual permaneceu constante até o fim do estudo. Por outro lado, somente as formulações 
contendo acetil hexapeptídeo-3 apresentaram efeito significativo nas propriedades mecânicas, por meio 
da diminuição da anisotropia da pele na face. Não foram observados efeitos significativos para os 
parâmetros de viscoelasticidade. Em conclusão, os efeitos de acetil hexapeptídeo-3 na pele caracteriza 
este peptídeo como um ingrediente ativo efetivo para a melhoria das condições cutâneas, quando utilizadas 
em formulações cosméticas.
Unitermos: Acetil hexapeptídeo-3/uso em cosméticos. Acetil hexapeptídeo-3/eficácia clínica. 
Antienvelhecimento/cosméticos. Cosméticos/formulação tópica/avaliação. Formulações tópicas/
antiidade.
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INTRODUCTION
In recent decades, cosmetic formulations have been 
developed and employed in the treatment or prevention 
of skin changes resulting from aging, such as loss of 
elasticity, dryness, formation of wrinkles and spots, thus, 
possible delaying invasive procedures such as plastic 
surgery. In this context, substances with anti-aging action 
have been proposed to delay the appearance of wrinkles 
or leaving them less visible. However, due to the high 
turnover in the cosmetic area, active substances and their 
cosmetic products are constantly available to commercial 
purposes without basic studies on the action mechanisms 
supporting their benefits (Hermanns-Lê et al., 2001).
The advances in the area of skin biology, such as the 
mechanisms involved in cell renewal, in skin aging and 
in the action of neuroendocrine receptors, have increased 
peptide importance. The skin is a neuroendocrine immune 
organ in which many different molecules operate in 
an autocrine-paracrine manner to guarantee tissue 
homeostatsis in physiological and pathophysiological 
condition (Sivilia et al., 2008; Takema et al., 1994). Due to 
their chemical structure, peptides may act in the hydration, 
skin protection and homeostasis, keeping cutaneous tissue 
healthy and with a young appearance. 
On the other hand, the search in the dermatology area 
for non-toxic molecules that mimic the action of botulinum 
neurotoxin, has identified acetyl hexapeptide-3 in a 
rational design program. An in vitro study demonstrated 
that acetyl hexapeptide-3 inhibits neurotransmitter release 
with a potency similar to that of botulinum neurotoxin, 
although as expected, it displayed much lower efficacy 
than the neurotoxin (Sivilia et al., 2008; Blanes-Mira et 
al., 2002).
However, there are few hardcore data about the 
effects of acetyl hexapeptíde-3 on epidermis and dermis, 
when vehiculated in topical formulations, under actual 
conditions of use, mainly using objective measurements, 
which are an important tool in clinical efficacy studies.
It should be considered that knowledge about the 
use of the acetyl hexapeptide-3 is just beginning and 
much remains to be learned. Thus, it is very important to 
elucidate the effects and prove the efficacy of this active 
ingredient, which is commonly used to improve the skin 
conditions because of the proposed antiaging activity. So, 
clinical objective studies to assess acetyl hexapeptide-3 
efficacy in the skin should rely on non-invasive skin 
biophysical techniques, which are often used to evaluate 
cosmetic products under actual conditions of use in human 
skin (Haftek et al., 2008; Paye et al., 2007; Uhoda et al., 
2002).
Furthermore, the results should contribute to a 
better understanding of the acetyl hexapeptide-3 effects 
by three biophysical techniques, Corneometer® CM 825, 
CutometerSEM 575 and ReviscometerRV600, in terms 
of skin hydration, skin elasticity and viscoelasticity, and 
skin anisotropy, showing that the peptide is clinically 
efficient and also that its use is very important in cosmetic 
formulations, due to its antiaging effects.
In this context, the aim of this study was to determine 
the real benefits of acetyl hexapeptide-3 on human skin, by 
analyzing the effects of a cosmetic formulation containing 
this active substance in terms of stratum corneum water 
content and skin mechanical properties.
MATERIAL AND METHODS
Test formulations
The vehicle formulation tested contained 3.5% 
(w/w) C12-20 acid PEG-8 ester, 0.7% (w/w), acrylate 
polymer, 2.5% (w/w) octyl octanoate, 2.0% (w/w) 
propylene glycol, 2.0% (w/w) glycerin, 2.0% (w/w) 
dimethicone DC 200/50CS, 7.5% (w/w) blend of 
UVA/UVB sunscreen (fenilbenzimidazol sulfonic 
acid, benzophenone-4) and 0.8% (w/w) blend of 
parabens and phenoxyethanol, Phenonip (Nipa Labs, 
Wilmington, USA). The formulations were supplemented 
or not with Argireline (solution containing 0.05% 
acetyl hexapeptide-3) to a concentration of 10%. Acetyl 
hexapeptide-3 was kindly provided by Galena Química e 
Farmacêutica Ltda, Campinas, Brazil. 
Study protocol
The study was approved by the Faculty of 
Pharmaceutical Sciences of Ribeirão Preto - USP Ethics 
Committee (CEP/FCFRP 60/2005). 
Forty healthy female subjects 35-55 years old having 
skin Fitzpatrick types II, III and IV participated in this 
study after having given their written informed consent. 
Exclusion criteria were the presence of any dermatitis and/
or other skin or allergic disease and smoking. Volunteers 
were instructed not to apply any topical products to the test 
sites for 2 weeks before and during the study. The subjects 
were allowed to wash normally, but not to use other skin 
care products on their arms and face. They were asked to 
avoid getting a sun tan, although the formulations applied 
had sunscreens in their composition to avoid the effects of 
daily exposure to UV radiation. 
Prior to all measurements, subjects remained in 
the room for at least 30 minutes in order to allow full 
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skin adaptation to room temperature (20 ± 2 ºC) and 
humidity (45-60%). Applications sites were randomized 
in order to minimize anatomic functional bias. The 
hydration index was assessed using measurements 
of capacitance (Corneometer CM825; Courage & 
Khazaka, Koeln, Germany) and the skin elasticity and 
viscoelasticity by cutometry (CutometerSEM 575; 
Courage & Khazaka) and by resonance running time 
measurements (ReviscometerRV600; Courage & 
Khazaka). The skin properties were examined using a 
standardized study protocol. 
After the baseline measurements, the subjects were 
instructed to apply 1.0 mL of the formulations with acetyl 
hexapeptide-3 on the ventral region of one forearm and 
the vehicle on the other forearm, twice daily. Half the 
subjects applied the 1.0 mL of formulation containing 
acetyl hexapeptide-3 on the full face and the other half, 
the vehicle. Measurements on forearms and cheeks were 
carried out 2 and 4 weeks after daily application, 10-15 
hours after the last treatment. For the last measurement, 
the formulations were applied in the evening and the 
measurements were taken in the following day (Savica 
et al., 2004).
Specifically, the experiment was conducted with 
twenty volunteers who were divided in two groups:
Group 1: application of the vehicle in the left 
forearm and in the face, and vehicle supplemented with 
acetyl hexapeptide-3 in the right forearm.
Group 2: application of the vehicle supplemented 
with acetyl hexapeptide-3 in the left forearm and in the 
face, and of the vehicle in the right forearm.
Instrumentation
The stratum corneum water content was determined 
with a non-invasive, skin capacitance meter (Corneometer® 
CM 825, Courage & Khazaka, Germany). The averaged 
values of twenty measurements were used for subsequent 
calculations (Dal’Belo, Gaspar, Maia Campos, 2006; 
Fluhr, Gloor, Lazzerini, 1999; Fluhr et al., 1999).
Mechanical properties of the skin were determined 
using two instruments, the CutometerSEM 575 (Courage 
& Khazaka, Germany) and ReviscometerRV600 (Courage 
& Khazaka, Germany). 
The measurement with CutometerSEM 575 
consisted of five consecutive cycles of a 2 s suction 
application period followed by a 2 s relaxation period. 
The suction load was 450 mbars. The method analyzed the 
following mechanical parameters: Ua/Uf, the ratio of total 
retraction to total distension, called gross elasticity; Ur/Ue, 
net-elasticity of the skin without viscous deformation; Uv/
Ue, the ratio of viscoelastic to elastic distension and Ur/
Uf, the ratio of immediate retraction to total distension, 
called biological elasticity (Dobrev, 2000; Dobrev, 2002). 
 The Reviscometer® RV600 is an equipment based 
on resonance running time measurements (RRTM) of 
acoustical shockwaves (Takema et al., 1994; Hermanns-
Lê et al. 2001; Ruvolo ; Stamatas ; Kollias, 2007). RRTM 
measurements were taken in precise directions, according 
to Uhoda et al.(2002), analyzing the medium RRTM, the 
lowest and highest RRTM (RRTM max and RRTM min). 
The anisotropy defined as the ratio between RRTM max 
and RRTM min was calculated (Stamatas, Kollias, 2007). 
Statistical analysis
Anisotropy calculated values were statistically 
analysed using the Kruskal-Wallis test. The other data 
showing a Gaussian distribution were evaluated by the 
ANOVA test. The values obtained by the vehicle and 
formulation with acetyl hexapeptide-3 after 4 weeks were 
statistically analysed using Mann- Whitney test for non-
parametric distribution, and unpaired t- test for parametric 
distribution. Differences were accepted as statistically 
significant at p < 0.05.
RESULTS AND DISCUSSION
Acetyl hexapeptide-3 has been used in anti-aging 
topical formulations due to its effects in improving 
the skin appearance (Blanes-Mira et al., 2002; Zhang, 
Falla, 2009). However there are few basic studies about 
its effects on skin, as well as, about its mechanism 
of action. In the present investigation, the efficacy 
of dermocosmetic formulations containing acetyl 
hexapeptide-3 was evaluated using biophysical techniques 
and the capacity of two instruments, the CutometerSEM 
575 and ReviscometerRV600, to identify skin changes 
was compared.
CutometerSEM 575 is a non-invasive skin-
elasticity meter that consists of a microprocessor-regulated 
pneumatic system that applies suction via a 2-mm circular 
opening in the handheld probe. Evaluation is based on 
measurements of skin deformation in response to suction. 
The Reviscometer® RV600 is a device equipped 
with a probe containing two needle-like sensors. When 
placed on the skin, one needle transmits ultrasound 
shockwaves and the other is the recipient. The time needed 
by waves to go from the transmitter to the recipient is the 
measured RRTM parameter expressed in arbitrary units. 
The resonance running time measurements (RRTM) of 
acoustical shockwaves propagates differently through 
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the skin according to the state of the elastic fibers and its 
moisture content (Takema et al., 1994; Hermanns-Lê et 
al. 2001; Ruvolo, Stamatas, Kollias, 2007).
Age-related cutaneous changes, such as wrinkles and 
skin laxity, are especially prominent on the facial skin, so 
several studies have used this site to evaluate the efficacy 
of cosmetic products (Takema et al., 1994; Sommerfeld, 
2007). On the other hand, the ventral forearm, which 
has limited exposure to sunlight and is an easier site for 
measurements, has also been used to evaluate changes 
characterizing chronological aging (Sumino et al., 2004). 
In this study, both regions were used to evaluate the effects 
of formulations with acetyl hexapeptide-3.
 Four weeks after applying formulations on the 
forearm skin, the stratum corneum water content showed 
an increasing tendency, not statistically significant, when 
compared to the baseline values (Figure 1) (p > 0.05). 
On the other hand, formulations with and without acetyl 
hexapeptide-3 increased water content of the stratum 
corneum in the face region (p < 0.01), which remained 
constant until the end of the study (4 weeks) (Figure 1). 
Thus, vehicle only also increased the stratum corneum 
water content to appropriate levels of hydration in a normal 
skin. These results are in line with previous data obtained 
by this research group, when peptide-containing emulsions 
were applied on the volunteers forearm skin once, and after 
a 4-week period the emulsion with or without peptides 
caused an enhanced skin hydration (Anconi, Campos, 
2008). Skin hydration is an important parameter to 
evaluate the efficacy of a substance. Moisturizing products 
may prevent skin alterations resulting from aging and may 
be used as support in the treatment of several skin diseases 
(Rawlings, Harding, 2004).
Corneometer® CM 825 is a device which determines 
the water content of superficial epidermal layers down to a 
depth of about 0.1 mm and expresses the values obtained 
in arbitrary units (Dal’Belo, Gaspar, Maia Campos, 2006; 
Fluhr, Gloor, Lazzerini, 1999; Fluhr et al., 1999). Our 
results showed that acetyl hexapeptide-3 did not increase 
stratum corneum water content, compared to the vehicle. 
The vehicle formulation is composed by emollients 
that can act on superficial moisturizing and acetyl 
hexapeptide-3 may effectively contribute to hydration of 
deeper layers of epidermis, which is not measured by this 
technique. 
In the study of mechanical properties, we compared 
the ability of two instruments, the Reviscometer® RVM600 
and the Cutometer® SEM 575, to detect skin surface 
mechanical changes. 
Data on shear wave propagation, obtained by the 
Reviscometer, are shown in Figures 2 to 5 and indicate 
that acetyl hexapeptide-3 exhibits a significant effect by 
decreasing the anisotropy property of face skin. Compared 
to the vehicle, this reduction was also significant on the 
face after 4 weeks (Figure 5B). Such a finding suggests 
increased firmness or tensor effect, since the speed of 
shear wave propagation on the skin surface is directly 
proportional to its stiffness (Ruvolo, Stamatas, Kollias, 
2007; Vexler, Polyansky, Gorodetsky, 1999). In rigid 
skin the time for wave spreading will be short, anisotropy 
and RRTM values smaller (Nizet, Pierard-Franchimont, 
Pierard, 2001; Verhaegen et al., 2010). 
Ruvolo, Stamatas and Kollias (2007) and Hermanns-
Lê et al. (2001) observed that while the minimum RRTM 
values remained fairly constant for the different age 
groups, the maximum RRTM values increased with age. 
FIGURE 1 - Skin stratum corneum water content before and after a 2 and 4-week long application of test formulations (vehicle, 
vehicle + acetyl hexapeptide-3) on the forearm (A) and face area (B) of volunteers. AHP: acetyl hexapeptide-3. *Significantly 
different from the baseline values (p<0.01).
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FIGURE 2 - Maximum RRTM before and after a 2 and 4-week long application of test formulations (vehicle, vehicle + acetyl 
hexapeptide-3) on the forearm (A) and face area (B) of volunteers. AHP: acetyl hexapeptide-3.
FIGURE 3 - Minimum RRTM before and after a 2 and 4-week long application of the test formulations (vehicle, vehicle + acetyl 
hexapeptide-3) on the forearm (A) and face area (B) of volunteers. AHP: acetyl hexapeptide-3.
FIGURE 4 - Medium RRTM before and after a 2 and 4-week long application of the test formulations (vehicle, vehicle + acetyl 
hexapeptide-3) on the forearm (A) and face area (B) of volunteers. AHP: acetyl hexapeptide-3.
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Thus, anisotropy is defined as the ratio between maximum 
and minimum RRTMs and will also increase with age. 
In contrast, in this study, the mean, maximum and 
minimum RRTM did not show alterations after treatment 
with formulations tested, meaning that they were less 
discriminatory between formulations when compared with 
anisotropy values.
It is concluded that acetyl hexapeptide-3 is an 
effective anti-aging compound as already mentioned 
by Blanes-Mira et al. (2002). The author, using silicone 
replicas, observed that topical application of an emulsion 
containing the peptide attenuated the depth of wrinkles 
in the periocular region after 30 days of treatment, when 
compared with the vehicle.
Unlike the results on the face region, formulations 
applied on the forearm did not cause any significant 
change in the skin anisotropy, suggesting that the effects 
of the cosmetic formulations in the two regions studied 
are different, the same as occurred in the determination of 
stratum corneum water content. This is due to the fact that 
face and forearm skin have quite different characteristics. 
The face is more vulnerable to photoaging than the forearms 
and more susceptible to the action of antiaging products 
(Blinchmann, Serup, 1988). According to Blinchmann and 
Serup (1988) and Rogiers (1990), variations in the skin 
characteristics in different regions of the body may also be 
related to differences in the stratum corneum thickness and 
the number and activity of sebaceous glands. 
Skin elasticity parameters were not significantly 
altered, after a 4-week period of daily application of 
formulations on both skin regions (Figures 6 and 7) 
as indicated by the lack of changes in the Cutometer®-
measured elasticity index. Thus, it is possible to conclude 
that the Reviscometer was better qualified to detect 
statistically significant effects of acetyl hexapeptide-3 
than the Cutometer. Paye et al. (2007) also noted that 
Reviscometer is able to better discriminate different 
treatments than the Cutometer, in a study involving 
induced slight xerotic skin conditions. 
In a previous retinoids efficacy study of our research 
group we observed that dermocosmetic formulations 
containing retinoic acid altered the skin anisotropy after a 
4-week period of daily applications, but these formulations 
did not alter the cutometer parameters. However, after 
a 8-week period of daily application, it was possible to 
detect alterations not only in skin anisotropy but also in 
cutometer parameters (Ua/Uf - the ratio of total retraction 
to total distension and Ur/Uf - the ratio of immediate 
retraction to total distension) (unpublished data). These 
observations suggest that significant changes in skin 
elasticity may occur later or these changes have to attain 
a certain level to be detected by the Cutometer .
Finally, it is necessary to consider that loss of 
skin elasticity is one of the main problems of aging 
and this is a mechanical property influenced by elastin, 
which together with collagen and glycosaminoglycans 
make up the connective tissue. As a large number of 
events cause cutaneous aging (Rieger, 1996), the use 
of active ingredients that are able to induce alterations 
in skin mechanical properties is a valid option for the 
improvement of skin conditions. In this context, the effects 
of acetyl hexapeptide-3 on the anisotropy of face skin, 
FIGURE 5 - Anisotropy (RRTMmaximum / RRTMminimum) before and after a 2 and 4-week long application of the test formulations 
(vehicle, vehicle + acetyl hexapeptide-3) on the forearm (A) and face area (B) of volunteers. AHP: acetyl hexapeptide-3. 
*Significantly different from baseline values; ● Significantly different from Vehicle after 4 weeks using the formulations.
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characterizes the compound as an effective ingredient for 
improving conditions of the cutaneous tissue, when used 
in anti-aging cosmetic formulations.
CONCLUSIONS
In this study, acetyl hexapeptide-3 was found to 
be an effective ingredient for use in anti-aging cosmetic 
formulations due to its reduction of the anisotropy of face 
skin and probable action on its mechanical properties. 
This way, it can be used in cosmetic formulations to 
prevent skin alterations, premature aging and improve 
skin conditions. 
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